Chen Xue
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 34
- MicroRNA in disease regulation 11
- Cancer, Lipids, and Metabolism 9
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Lanjuan Li (17 shared papers)Ganglei Li (7 shared papers)Juan Lü (5 shared papers)Zhengyi Bao (9 shared papers)Xinyu Gu (13 shared papers)Yalei Zhao (5 shared papers)Qiuxian Zheng (4 shared papers)Gary E. Striker (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)International Journal of Molecular Sciences (3 papers)Scientific Reports (2 papers)Frontiers in Cell and Developmental Biology (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Chen Xue
119 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 136
- Cancer Research 1.0k
- Clinical Biochemistry 170
- Molecular Biology 1.6k
- Immunology 232
- Oncology 262
Countries citing papers authored by Chen Xue
This map shows the geographic impact of Chen Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Xue more than expected).
Fields of papers citing papers by Chen Xue
This network shows the impact of papers produced by Chen Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Xue. The network helps show where Chen Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 147 | |
| 2 | 2008 | 146 | |
| 3 | 2022 | 133 | |
| 4 | 2021 | 104 | |
| 5 | 2020 | 97 | |
| 6 | 2022 | 94 | |
| 7 | 2014 | 84 | |
| 8 | 2018 | 72 | |
| 9 | 2007 | 66 | |
| 10 | 2018 | 65 | |
| 11 | 2010 | 64 | |
| 12 | 2020 | 60 | |
| 13 | 2020 | 56 | |
| 14 | 2016 | 51 | |
| 15 | 2018 | 45 | |
| 16 | 2006 | 45 | |
| 17 | Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma. | 2018 | 44 |
| 18 | 2019 | 43 | |
| 19 | 2020 | 43 | |
| 20 | 2021 | 41 |
About Chen Xue
Chen Xue is a scholar working on Cancer Research, Hepatology, Applied Microbiology and Biotechnology, Molecular Biology and Biological Psychiatry, having authored 125 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (34 papers), RNA modifications and cancer (28 papers), Circular RNAs in diseases (13 papers), Cancer-related gene regulation (13 papers), MicroRNA in disease regulation (11 papers), Cancer, Lipids, and Metabolism (9 papers), Ferroptosis and cancer prognosis (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). The work is most often cited by research in Cancer Research (1.0k citations), Clinical Biochemistry (170 citations), Molecular Biology (1.6k citations), Immunology (232 citations) and Oncology (262 citations). Chen Xue has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Lanjuan Li, Ganglei Li, Juan Lü, Zhengyi Bao, Xinyu Gu, Yalei Zhao, Qiuxian Zheng, Gary E. Striker, Yuanshuai Su and Li Zhu. Their work appears in journals such as Biomedicine & Pharmacotherapy, International Journal of Molecular Sciences, Scientific Reports, Frontiers in Cell and Developmental Biology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.